These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15719399)

  • 1. Erythropoietin is approved for the treatment of anemia associated with renal failure, chemotherapy, preoperative anemia, and human immunodeficiency virus disease.
    Savur S; Bonacini M; Bzowej N; Gish R; Wakil A; Osorio R
    Liver Transpl; 2005 Mar; 11(3):366. PubMed ID: 15719399
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure.
    van der Putten K; Braam B; Jie KE; Gaillard CA
    Nat Clin Pract Nephrol; 2008 Jan; 4(1):47-57. PubMed ID: 18094727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gaining time in the treatment of anemia of patients with kidney failure].
    Rigal F
    Soins; 2008 Nov; (730):33-4. PubMed ID: 19068911
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic anemia after lung transplantation: treatment with human recombinant erythropoietin.
    End A; Ringl H; Grimm M; Schlick W; Schreiner W; Klepetko W; Wolner E
    Transplantation; 1994 Apr; 57(7):1142. PubMed ID: 8165717
    [No Abstract]   [Full Text] [Related]  

  • 5. The end stage renal disease program.
    Goodkin DA
    N Engl J Med; 1993 Jul; 329(2):140; author reply 140-1. PubMed ID: 8510703
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevalence of anti-erythropoietin antibodies in hemodialysis patients without clinical signs of pure red cell aplasia. Comparison between hypo- and normoresponsive patients treated with epoetins for renal anemia.
    Stoffel MP; Haverkamp H; Kromminga A; Lauterbach KW; Baldamus CA
    Nephron Clin Pract; 2007; 105(2):c90-8. PubMed ID: 17164586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Erythropoietin treatment of anemia associated with human immunodeficiency virus infection].
    Moreno García M
    Med Clin (Barc); 1997 Feb; 108(7):266-71. PubMed ID: 9121196
    [No Abstract]   [Full Text] [Related]  

  • 8. Hyporesponsiveness to erythropoietic therapy due to chronic inflammation.
    Macdougall IC; Cooper AC
    Eur J Clin Invest; 2005 Dec; 35 Suppl 3():32-5. PubMed ID: 16281956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin-resistant anaemia in a predialysis patient with Klinefelter syndrome.
    Shimizu Y; Suzukawa K; Hirano Y; Seki M; Hirayama K; Yoh K; Hirayama A; Yamagata K; Nagase S; Nagasawa T; Koyama A
    Nephrology (Carlton); 2005 Apr; 10(2):147-50. PubMed ID: 15877674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis and therapy of renal anemia. Iron levels should be watched carefully: MMW Seminar on Anemia. 2].
    Hörl WH
    MMW Fortschr Med; 1999 Jun; 141(24):47-8. PubMed ID: 10468495
    [No Abstract]   [Full Text] [Related]  

  • 11. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
    Nakamoto H; Mimura T; Honda N
    Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose erythropoietin treatment of anaemia associated with operative transfusion haemolysis and acute renal failure.
    Walter J; Kun K; Doman J
    Nephrol Dial Transplant; 1992; 7(6):559-60. PubMed ID: 1320238
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of recombinant human erythropoietin in anemia of malignancy.
    Cazzola M
    Med Oncol; 1998 Aug; 15 Suppl 1():S1-2. PubMed ID: 9785329
    [No Abstract]   [Full Text] [Related]  

  • 14. Congestive heart failure-related anemia and a role for erythropoietin.
    Akram K; Pearlman BL
    Int J Cardiol; 2007 May; 117(3):296-305. PubMed ID: 16901559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin safety and efficacy in chronic allograft nephropathy.
    Baltar J; Moran N; Ortega F; Ortega T; Rebollo P; Cofan F; Campistol JM
    Transplant Proc; 2007 Sep; 39(7):2245-7. PubMed ID: 17889152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaemia and heart failure: aetiology and treatment.
    Klutstein MW; Tzivoni D
    Nephrol Dial Transplant; 2005 Jul; 20 Suppl 7():vii7-10. PubMed ID: 16024833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The deadly triangle of anemia, renal insufficiency, and cardiovascular disease: implications for prognosis and treatment.
    McCullough PA; Lepor NE
    Rev Cardiovasc Med; 2005; 6(1):1-10. PubMed ID: 15741920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of erythropoietin].
    Godin M
    Soins; 2004 Sep; (688 Suppl):5. PubMed ID: 15526820
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapy insight: congestive heart failure, chronic kidney disease and anemia, the cardio-renal-anemia syndrome.
    Iaina A; Silverberg DS; Wexler D
    Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):95-100. PubMed ID: 16265380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can higher hematocrits prove of value for ESRD patients?
    Nephrol News Issues; 1999 Sep; 13(9):30-1. PubMed ID: 10776250
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.